Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, is a common clinical presentation with a broad differential diagnosis. Its evaluation and management can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to understanding and managing syncope for healthcare professionals.
Syncope can be categorized into three broad categories: reflex, orthostatic hypotension, and cardiac. Reflex syncope, also known as neurally mediated syncope, includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension is caused by a drop in blood pressure upon standing. Cardiac syncope can be due to arrhythmias or structural heart disease.
A thorough history and physical examination are paramount in the evaluation of syncope. Specific attention should be given to the circumstances surrounding the syncopal event, including prodromal symptoms, position during the event, and recovery period. Diagnostic tests should be guided by clinical suspicion based on the history and physical examination.
The management of syncope depends on the underlying cause. Reflex syncope is usually managed with lifestyle modifications and reassurance. Orthostatic hypotension may require medication adjustments, volume expansion, and physical counterpressure maneuvers. Cardiac syncope may necessitate medical or surgical interventions, including pacemaker implantation or cardiac ablation.
Syncope is a complex clinical entity that requires a comprehensive approach for effective evaluation and management. A thorough understanding of its etiology, pathophysiology, clinical evaluation, and management strategies is essential for healthcare professionals to ensure optimal patient care.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation